-
1
-
-
0033950307
-
Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms
-
Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000;24:203-10
-
(2000)
Am J Surg Pathol
, vol.24
, pp. 203-210
-
-
Avery, A.K.1
Beckstead, J.2
Renshaw, A.A.3
Corless, C.L.4
-
2
-
-
4344694453
-
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System
-
Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865-72
-
(2004)
J Clin Oncol
, vol.22
, pp. 2865-2872
-
-
Barnholtz-Sloan, J.S.1
Sloan, A.E.2
Davis, F.G.3
Vigneau, F.D.4
Lai, P.5
Sawaya, R.E.6
-
3
-
-
84857030136
-
Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases
-
Capper D, Berghoff AS, Magerle M, Ilhan A, Wohrer A, Hackl M, et al. Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases. Acta Neuropathol 2012;123: 223-33
-
(2012)
Acta Neuropathol
, vol.123
, pp. 223-233
-
-
Capper, D.1
Berghoff, A.S.2
Magerle, M.3
Ilhan, A.4
Wohrer, A.5
Hackl, M.6
-
4
-
-
79959580390
-
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
-
Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, et al. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 2011;122:11-9
-
(2011)
Acta Neuropathol
, vol.122
, pp. 11-19
-
-
Capper, D.1
Preusser, M.2
Habel, A.3
Sahm, F.4
Ackermann, U.5
Schindler, G.6
-
5
-
-
79251551994
-
PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system
-
Carney EM, Banerjee P, Ellis CL, Albadine R, Sharma R, Chaux AM, et al. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system. Am J Surg Pathol 2011;35:262-7
-
(2011)
Am J Surg Pathol
, vol.35
, pp. 262-267
-
-
Carney, E.M.1
Banerjee, P.2
Ellis, C.L.3
Albadine, R.4
Sharma, R.5
Chaux, A.M.6
-
6
-
-
74049127174
-
Leptomeningeal metastasis
-
Chamberlain MC. Leptomeningeal metastasis. Curr Opin Neurol 2009;22:665-74
-
(2009)
Curr Opin Neurol
, vol.22
, pp. 665-674
-
-
Chamberlain, M.C.1
-
7
-
-
80255132751
-
Brain, the last fortress of sarcoma: Similar dismal outcome but discrepancy of timing of brain metastasis in bone and soft tissue sarcoma
-
Chou YS, Liu CY, Chen WM, Chen TH, Chen PC, Wu HT, et al. Brain, the last fortress of sarcoma: Similar dismal outcome but discrepancy of timing of brain metastasis in bone and soft tissue sarcoma. J Surg Oncol 2011;104:765-70
-
(2011)
J Surg Oncol
, vol.104
, pp. 765-770
-
-
Chou, Y.S.1
Liu, C.Y.2
Chen, W.M.3
Chen, T.H.4
Chen, P.C.5
Wu, H.T.6
-
8
-
-
0033795923
-
Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases
-
Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod Pathol 2000;13:962-72
-
(2000)
Mod Pathol
, vol.13
, pp. 962-972
-
-
Chu, P.1
Wu, E.2
Weiss, L.M.3
-
9
-
-
0036143244
-
Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohistochemical study of 509 cases
-
Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohistochemical study of 509 cases. Mod Pathol 2002;15:6-10
-
(2002)
Mod Pathol
, vol.15
, pp. 6-10
-
-
Chu, P.G.1
Weiss, L.M.2
-
10
-
-
0036090767
-
Keratin expression in human tissues and neoplasms
-
Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002;40:403-39
-
(2002)
Histopathology
, vol.40
, pp. 403-439
-
-
Chu, P.G.1
Weiss, L.M.2
-
11
-
-
34548145113
-
Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: A retrospective single-center study
-
Cicin I, Karagol H, Uzunoglu S, Uygun K, Usta U, Kocak Z, et al. Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: A retrospective single-center study. Cancer 2007;110:1068-76
-
(2007)
Cancer
, vol.110
, pp. 1068-1076
-
-
Cicin, I.1
Karagol, H.2
Uzunoglu, S.3
Uygun, K.4
Usta, U.5
Kocak, Z.6
-
12
-
-
67849090836
-
Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer
-
Daniele L, Cassoni P, Bacillo E, Cappia S, Righi L, Volante M, et al. Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer. J Thorac Oncol 2009;4:684-8
-
(2009)
J Thorac Oncol
, vol.4
, pp. 684-688
-
-
Daniele, L.1
Cassoni, P.2
Bacillo, E.3
Cappia, S.4
Righi, L.5
Volante, M.6
-
14
-
-
0033932661
-
Cytokeratin 7 and 20 expression in choroid plexus tumors: Utility in differentiating these neoplasms from metastatic carcinomas
-
Gyure KA, Morrison AL. Cytokeratin 7 and 20 expression in choroid plexus tumors: Utility in differentiating these neoplasms from metastatic carcinomas. Mod Pathol 2000;13:638-43
-
(2000)
Mod Pathol
, vol.13
, pp. 638-643
-
-
Gyure, K.A.1
Morrison, A.L.2
-
15
-
-
40149108470
-
Application of immunohistochemistry to the genitourinary system (prostate, urinary bladder, testis, and kidney)
-
Hammerich KH, Ayala GE, Wheeler TM. Application of immunohistochemistry to the genitourinary system (prostate, urinary bladder, testis, and kidney). Arch Pathol Lab Med 2008;132:432-40
-
(2008)
Arch Pathol Lab Med
, vol.132
, pp. 432-440
-
-
Hammerich, K.H.1
Ayala, G.E.2
Wheeler, T.M.3
-
16
-
-
80155181501
-
EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: Discordance in pleural metastases
-
Han HS, Eom DW, Kim JH, Kim KH, Shin HM, An JY, et al. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: Discordance in pleural metastases. Clin Lung Cancer 2011;12:380-6
-
(2011)
Clin Lung Cancer
, vol.12
, pp. 380-386
-
-
Han, H.S.1
Eom, D.W.2
Kim, J.H.3
Kim, K.H.4
Shin, H.M.5
An, J.Y.6
-
17
-
-
33645093483
-
Identification of novel diagnostic markers for choroid plexus tumors: A microarray-based approach
-
Hasselblatt M, Bohm C, Tatenhorst L, Dinh V, Newrzella D, Keyvani K, et al. Identification of novel diagnostic markers for choroid plexus tumors: A microarray-based approach. Am J Surg Pathol 2006;30:66-74
-
(2006)
Am J Surg Pathol
, vol.30
, pp. 66-74
-
-
Hasselblatt, M.1
Bohm, C.2
Tatenhorst, L.3
Dinh, V.4
Newrzella, D.5
Keyvani, K.6
-
18
-
-
84877940932
-
Case report 371: Alveolar soft parts sarcoma (brain and thigh)
-
Howard BA, Rubenstein JD, Lewis AJ. Case report 371: Alveolar soft parts sarcoma (brain and thigh). Skeletal Radiol 1986;15:468-72
-
(1986)
Skeletal Radiol
, vol.15
, pp. 468-472
-
-
Howard, B.A.1
Rubenstein, J.D.2
Lewis, A.J.3
-
19
-
-
78249232963
-
Factors associated with the development of brain metastases: Analysis of 975 patients with early stage nonsmall cell lung cancer
-
Hubbs JL, Boyd JA, Hollis D, Chino JP, Saynak M, Kelsey CR. Factors associated with the development of brain metastases: Analysis of 975 patients with early stage nonsmall cell lung cancer. Cancer 2010;116:5038-46
-
(2010)
Cancer
, vol.116
, pp. 5038-5046
-
-
Hubbs, J.L.1
Boyd, J.A.2
Hollis, D.3
Chino, J.P.4
Saynak, M.5
Kelsey, C.R.6
-
20
-
-
0030008053
-
Predilection of brain metastasis in gray and white matter junction and vascular border zones
-
Hwang TL, Close TP, Grego JM, Brannon WL, Gonzales F. Predilection of brain metastasis in gray and white matter junction and vascular border zones. Cancer 1996;77:1551-5
-
(1996)
Cancer
, vol.77
, pp. 1551-1555
-
-
Hwang, T.L.1
Close, T.P.2
Grego, J.M.3
Brannon, W.L.4
Gonzales, F.5
-
21
-
-
40149100486
-
Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung
-
Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med 2008;132:384-96
-
(2008)
Arch Pathol Lab Med
, vol.132
, pp. 384-396
-
-
Jagirdar, J.1
-
23
-
-
0034105401
-
Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites
-
Kaufmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000;36:415-20
-
(2000)
Histopathology
, vol.36
, pp. 415-420
-
-
Kaufmann, O.1
Dietel, M.2
-
24
-
-
0035184548
-
Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas
-
Kaufmann O, Fietze E, Mengs J, Dietel M. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001;116:823-30
-
(2001)
Am J Clin Pathol
, vol.116
, pp. 823-830
-
-
Kaufmann, O.1
Fietze, E.2
Mengs, J.3
Dietel, M.4
-
26
-
-
0033054670
-
Identification of prognostic factors in patients with brain metastases: A review of 1292 patients
-
Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: A review of 1292 patients. Int J Radiat Oncol Biol Phys 1999;43:795-803
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.43
, pp. 795-803
-
-
Lagerwaard, F.J.1
Levendag, P.C.2
Nowak, P.J.3
Eijkenboom, W.M.4
Hanssens, P.E.5
Schmitz, P.I.6
-
27
-
-
79958019473
-
A comprehensive analysis of PAX8 expression in human epithelial tumors
-
Laury AR, Perets R, Piao H, Krane JF, Barletta JA, French C, et al. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol 2011;35:816-26
-
(2011)
Am J Surg Pathol
, vol.35
, pp. 816-826
-
-
Laury, A.R.1
Perets, R.2
Piao, H.3
Krane, J.F.4
Barletta, J.A.5
French, C.6
-
28
-
-
84871427141
-
-
European Society for Medical Oncology October 8-12; Milan, Italy: ESMO
-
Long GK, Kefford RF, Carr P, Brown MP, Curtis M, Ma B, Lebowitz P, et al. Phase 1/2 Study of GSK2118436, a Selective Inhibitor of V600 Mutant (Mut) BRAF Kinase: Evidence of Activity in Melanoma Brain Metastases (Mets). European Society for Medical Oncology; October 8-12; Milan, Italy: ESMO; 2010
-
(2010)
Phase 1/2 Study of GSK2118436, A Selective Inhibitor of V600 Mutant (Mut) BRAF Kinase: Evidence of Activity in Melanoma Brain Metastases (Mets)
-
-
Long, G.K.1
Kefford, R.F.2
Carr, P.3
Brown, M.P.4
Curtis, M.5
Ma, B.6
Lebowitz, P.7
-
29
-
-
0036090423
-
Brain metastases from bladder carcinoma: Presentation, treatment and survival
-
Mahmoud-Ahmed AS, Suh JH, Kupelian PA, Klein EA, Peereboom DM, Dreicer R, et al. Brain metastases from bladder carcinoma: Presentation, treatment and survival. J Urol 2002;167:2419-22
-
(2002)
J Urol
, vol.167
, pp. 2419-2422
-
-
Mahmoud-Ahmed, A.S.1
Suh, J.H.2
Kupelian, P.A.3
Klein, E.A.4
Peereboom, D.M.5
Dreicer, R.6
-
30
-
-
25444440164
-
Diagnostic evaluation of patients with a brain mass as the presenting manifestation of cancer
-
Mavrakis AN, Halpern EF, Barker FG 2 nd, Gonzalez RG, Henson JW. Diagnostic evaluation of patients with a brain mass as the presenting manifestation of cancer. Neurology 2005;65:908-11
-
(2005)
Neurology
, vol.65
, pp. 908-911
-
-
Mavrakis, A.N.1
Halpern, E.F.2
Barker, I.I.F.G.3
Gonzalez, R.G.4
Henson, J.W.5
-
31
-
-
0026561237
-
Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies
-
Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-47
-
(1992)
Am J Pathol
, vol.140
, pp. 427-447
-
-
Moll, R.1
Lowe, A.2
Laufer, J.3
Franke, W.W.4
-
32
-
-
78650862148
-
Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6
-
Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol 2011;35:15-25
-
(2011)
Am J Surg Pathol
, vol.35
, pp. 15-25
-
-
Mukhopadhyay, S.1
Katzenstein, A.L.2
-
33
-
-
84892783723
-
Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients
-
[In Press]
-
Nakamura R, Yamamoto N, Onai Y, Watanabe Y, Kawana H, Miyazaki M. Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients. Breast Cancer 2012. [In Press]
-
(2012)
Breast Cancer
-
-
Nakamura, R.1
Yamamoto, N.2
Onai, Y.3
Watanabe, Y.4
Kawana, H.5
Miyazaki, M.6
-
35
-
-
80054053337
-
Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: Discordance rates and prognosis
-
Nishimura R, Osako T, Okumura Y, Tashima R, Toyozumi Y, Arima N. Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: Discordance rates and prognosis. World J Surg Oncol 2011;9:131
-
(2011)
World J Surg Oncol
, vol.9
, pp. 131
-
-
Nishimura, R.1
Osako, T.2
Okumura, Y.3
Tashima, R.4
Toyozumi, Y.5
Arima, N.6
-
36
-
-
0029740191
-
Brain metastases. Histology, multiplicity, surgery, and survival
-
Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996;78:1781-8
-
(1996)
Cancer
, vol.78
, pp. 1781-1788
-
-
Nussbaum, E.S.1
Djalilian, H.R.2
Cho, K.H.3
Hall, W.A.4
-
37
-
-
34447302348
-
Miliary brain metastasis presenting with dementia: Progression pattern of cancer metastases in the cerebral cortex
-
Ogawa M, Kurahashi K, Ebina A, Kaimori M, Wakabayashi K. Miliary brain metastasis presenting with dementia: Progression pattern of cancer metastases in the cerebral cortex. Neuropathology 2007;27:390-5
-
(2007)
Neuropathology
, vol.27
, pp. 390-395
-
-
Ogawa, M.1
Kurahashi, K.2
Ebina, A.3
Kaimori, M.4
Wakabayashi, K.5
-
38
-
-
0032862110
-
Evaluation of epithelial and keratin markers in glioblastoma multiforme: An immunohistochemical study
-
Oh D, Prayson RA. Evaluation of epithelial and keratin markers in glioblastoma multiforme: An immunohistochemical study. Arch Pathol Lab Med 1999;123:917-20
-
(1999)
Arch Pathol Lab Med
, vol.123
, pp. 917-920
-
-
Oh, D.1
Prayson, R.A.2
-
40
-
-
58549085258
-
Pathologic evaluation of unknown primary cancer
-
Oien KA. Pathologic evaluation of unknown primary cancer. Semin Oncol 2009;36:8-37
-
(2009)
Semin Oncol
, vol.36
, pp. 8-37
-
-
Oien, K.A.1
-
41
-
-
0034994431
-
Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites
-
Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Lloyd RV. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 2001;25:815-9
-
(2001)
Am J Surg Pathol
, vol.25
, pp. 815-819
-
-
Oliveira, A.M.1
Tazelaar, H.D.2
Myers, J.L.3
Erickson, L.A.4
Lloyd, R.V.5
-
42
-
-
0033843564
-
Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas
-
Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 2000;24:1217-23
-
(2000)
Am J Surg Pathol
, vol.24
, pp. 1217-1223
-
-
Ordonez, N.G.1
-
43
-
-
0037215340
-
Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas
-
Parker DC, Folpe AL, Bell J, Oliva E, Young RH, Cohen C, et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol 2003;27:1-10
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 1-10
-
-
Parker, D.C.1
Folpe, A.L.2
Bell, J.3
Oliva, E.4
Young, R.H.5
Cohen, C.6
-
44
-
-
0242392011
-
The management of brain metastases
-
Patchell RA. The management of brain metastases. Cancer Treat Rev 2003;29:533-40
-
(2003)
Cancer Treat Rev
, vol.29
, pp. 533-540
-
-
Patchell, R.A.1
-
45
-
-
0025189608
-
A randomized trial of surgery in the treatment of single metastases to the brain
-
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500
-
(1990)
N Engl J Med
, vol.322
, pp. 494-500
-
-
Patchell, R.A.1
Tibbs, P.A.2
Walsh, J.W.3
Dempsey, R.J.4
Maruyama, Y.5
Kryscio, R.J.6
-
46
-
-
34548497417
-
Switching benchmarks in cancer of unknown primary: From autopsy to microarray
-
Pentheroudakis G, Golfinopoulos V, Pavlidis N. Switching benchmarks in cancer of unknown primary: From autopsy to microarray. Eur J Cancer 2007;43:2026-36
-
(2007)
Eur J Cancer
, vol.43
, pp. 2026-2036
-
-
Pentheroudakis, G.1
Golfinopoulos, V.2
Pavlidis, N.3
-
47
-
-
0028097734
-
Metastatic alveolar soft part sarcoma presenting as a dural-based cerebral mass
-
Perry JR, Bilbao JM. Metastatic alveolar soft part sarcoma presenting as a dural-based cerebral mass. Neurosurgery 1994;34:168-70
-
(1994)
Neurosurgery
, vol.34
, pp. 168-170
-
-
Perry, J.R.1
Bilbao, J.M.2
-
48
-
-
77957607641
-
Clear cell meningioma: A clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma
-
Prayson RA, Chamberlain WA, Angelov L. Clear cell meningioma: A clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma. Appl Immunohistochem Mol Morphol 2010;18:422-8
-
(2010)
Appl Immunohistochem Mol Morphol
, vol.18
, pp. 422-428
-
-
Prayson, R.A.1
Chamberlain, W.A.2
Angelov, L.3
-
49
-
-
0025248447
-
Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas
-
Ramaekers F, van Niekerk C, Poels L, Schaafsma E, Huijsmans A, Robben H, et al. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990;136:641-55
-
(1990)
Am J Pathol
, vol.136
, pp. 641-655
-
-
Ramaekers, F.1
Van Niekerk, C.2
Poels, L.3
Schaafsma, E.4
Huijsmans, A.5
Robben, H.6
-
50
-
-
78149264152
-
Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma
-
Rivera AL, Takei H, Zhai J, Shen SS, Ro JY, Powell SZ. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma. Neuropathology 2010;30:580-5
-
(2010)
Neuropathology
, vol.30
, pp. 580-585
-
-
Rivera, A.L.1
Takei, H.2
Zhai, J.3
Shen, S.S.4
Ro, J.Y.5
Powell, S.Z.6
-
51
-
-
84866400455
-
Sox 10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses
-
Shin J, Vincent JG, Cuda JD, Xu H, Kang S, Kim J, et al. Sox 10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses. J Am Acad Dermatol 2012;67:717-26
-
(2012)
J Am Acad Dermatol
, vol.67
, pp. 717-726
-
-
Shin, J.1
Vincent, J.G.2
Cuda, J.D.3
Xu, H.4
Kang, S.5
Kim, J.6
-
54
-
-
0036324601
-
Immunohistochemical staining for thyroid transcription factor-1: A helpful aid in discerning primary site of tumor origin in patients with brain metastases
-
Srodon M, Westra WH. Immunohistochemical staining for thyroid transcription factor-1: A helpful aid in discerning primary site of tumor origin in patients with brain metastases. Hum Pathol 2002;33:642-5
-
(2002)
Hum Pathol
, vol.33
, pp. 642-645
-
-
Srodon, M.1
Westra, W.H.2
-
55
-
-
78650169667
-
Surgical treatment for brain metastases: Prognostic factors and survival in 309 patients with regard to patient age
-
Stark AM, Stohring C, Hedderich J, Held-Feindt J, Mehdorn HM. Surgical treatment for brain metastases: Prognostic factors and survival in 309 patients with regard to patient age. J Clin Neurosci 2011;18:34-8
-
(2011)
J Clin Neurosci
, vol.18
, pp. 34-38
-
-
Stark, A.M.1
Stohring, C.2
Hedderich, J.3
Held-Feindt, J.4
Mehdorn, H.M.5
-
56
-
-
4344625815
-
Alveolar soft-part sarcoma presenting with multiple intracranial metastases
-
Sujit Kumar GS, Chacko G, Chacko AG, Rajshekhar V. Alveolar soft-part sarcoma presenting with multiple intracranial metastases. Neurol India 2004;52:257-8
-
(2004)
Neurol India
, vol.52
, pp. 257-258
-
-
Sujit Kumar, G.S.1
Chacko, G.2
Chacko, A.G.3
Rajshekhar, V.4
-
57
-
-
25444521990
-
Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs
-
Suzuki A, Shijubo N, Yamada G, Ichimiya S, Satoh M, Abe S, et al. Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs. Pathol Res Pract 2005;201:579-86
-
(2005)
Pathol Res Pract
, vol.201
, pp. 579-586
-
-
Suzuki, A.1
Shijubo, N.2
Yamada, G.3
Ichimiya, S.4
Satoh, M.5
Abe, S.6
-
58
-
-
27644528997
-
Leptomeningeal metastases from solid malignancy: A review
-
Taillibert S, Laigle-Donadey F, Chodkiewicz C, Sanson M, Hoang-Xuan K, Delattre JY. Leptomeningeal metastases from solid malignancy: A review. J Neurooncol 2005;75:85-99
-
(2005)
J Neurooncol
, vol.75
, pp. 85-99
-
-
Taillibert, S.1
Laigle-Donadey, F.2
Chodkiewicz, C.3
Sanson, M.4
Hoang-Xuan, K.5
Delattre, J.Y.6
-
59
-
-
65649132325
-
Tumor-to-tumor metastasis to the central nervous system
-
Takei H, Powell SZ. Tumor-to-tumor metastasis to the central nervous system. Neuropathology 2009;29:303-8
-
(2009)
Neuropathology
, vol.29
, pp. 303-308
-
-
Takei, H.1
Powell, S.Z.2
-
60
-
-
0037371192
-
CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: An immunohistochemical survey of 476 primary and metastatic carcinomas
-
Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: An immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 2003;27:303-10
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 303-310
-
-
Werling, R.W.1
Yaziji, H.2
Bacchi, C.E.3
Gown, A.M.4
-
61
-
-
0024512152
-
Gross cystic disease fluid protein-15 as a marker for breast cancer: Immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin
-
Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT. Gross cystic disease fluid protein-15 as a marker for breast cancer: Immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol 1989;20:281-7
-
(1989)
Hum Pathol
, vol.20
, pp. 281-287
-
-
Wick, M.R.1
Lillemoe, T.J.2
Copland, G.T.3
Swanson, P.E.4
Manivel, J.C.5
Kiang, D.T.6
-
62
-
-
0343953568
-
Surgical treatment of brain metastases from melanoma: A retrospective study of 91 patients
-
Wronski M, Arbit E. Surgical treatment of brain metastases from melanoma: A retrospective study of 91 patients. J Neurosurg 2000;93:9-18
-
(2000)
J Neurosurg
, vol.93
, pp. 9-18
-
-
Wronski, M.1
Arbit, E.2
-
63
-
-
0342313452
-
Surgical resection of brain metastases from renal cell carcinoma in 50 patients
-
Wronski M, Arbit E, Russo P, Galicich JH. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology 1996;47:187-93
-
(1996)
Urology
, vol.47
, pp. 187-193
-
-
Wronski, M.1
Arbit, E.2
Russo, P.3
Galicich, J.H.4
-
64
-
-
77952011329
-
A study of immunohistochemical differential expression in pulmonary and mammary carcinomas
-
Yang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol 2010;23:654-61
-
(2010)
Mod Pathol
, vol.23
, pp. 654-661
-
-
Yang, M.1
Nonaka, D.2
-
65
-
-
0019456972
-
Intracerebral metastases in solid-tumor patients: Natural history and results of treatment
-
Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid-tumor patients: Natural history and results of treatment. Cancer 1981;48:384-94
-
(1981)
Cancer
, vol.48
, pp. 384-394
-
-
Zimm, S.1
Wampler, G.L.2
Stablein, D.3
Hazra, T.4
Young, H.F.5
|